Idera Pharmaceuticals Inc (IDRA)
2.28
+0.24 +11.76%
NASDAQ
Sep 25, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.65 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -49.77M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 80.25M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | -- |
| PE Ratio | -- |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -- |
| Free Cash Flow (Quarterly) | -8.352M |
| Return on Equity | Upgrade |
View All IDRA News
News
-
WireHeadlineTime (ET)
-
Globe Newswire09/15 07:18
-
Yahoo09/10 10:13
-
MT Newswires09/03 05:41
-
SA Breaking News08/25 11:06
-
SA Breaking News08/04 17:13
-
Globe Newswire08/04 16:10
-
SA Breaking News07/20 11:02
-
PR Newswire07/20 09:31
-
SA Breaking News07/20 08:29
-
MT Newswires07/15 15:53
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 11/06/2020 | Earnings | Idera Pharmaceuticals Inc Third Quarter Earnings Results for 2020 |
| 08/04/2020 | Earnings | Idera Pharmaceuticals Inc Second Quarter Earnings Results for 2020 |
| 05/12/2020 | Misc | Idera Pharmaceuticals Inc Annual General Meeting for 2019 |
| 04/30/2020 | Earnings | Idera Pharmaceuticals Inc First Quarter Earnings Results for 2020 |
| 03/12/2020 | Misc | Idera Pharmaceuticals Inc Annual Report for 2019 |
| 03/11/2020 | Earnings | Idera Pharmaceuticals Inc Fourth Quarter Earnings Results for 2019 |
| 11/06/2019 | Earnings | Idera Pharmaceuticals Inc Third Quarter Earnings Results for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.iderapharma.com
- Investor Relations URL: http://ir.iderapharma.com/phoenix.zhtml?c=208904&p=irol-irhome
- HQ State/Province: Pennsylvania
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Growth
- Next Earnings Release: Nov. 06, 2020
- Last Earnings Release: Aug. 04, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Idera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases. The company has developed two distinct proprietary drug-discovery technology platforms: Toll-like receptor and third-generation antisense technology. The Toll-like receptor technology helped the company create synthetic oligonucleotide-based drug candidates.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 2.28 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- IDRA Tweets Stocktwits
Advertisement
